Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

2012 ◽  
Vol 134 (1) ◽  
pp. 283-289 ◽  
Author(s):  
Marta Pestrin ◽  
Silvia Bessi ◽  
Fabio Puglisi ◽  
Alessandro M. Minisini ◽  
Giovanna Masci ◽  
...  
PLoS ONE ◽  
2013 ◽  
Vol 8 (5) ◽  
pp. e62543 ◽  
Author(s):  
Justin Stebbing ◽  
Rachel Payne ◽  
Justine Reise ◽  
Adam E. Frampton ◽  
Miranda Avery ◽  
...  

2011 ◽  
Vol 17 (2) ◽  
pp. 96-104 ◽  
Author(s):  
Naoki Hayashi ◽  
Seigo Nakamura ◽  
Yasuharu Tokuda ◽  
Yuji Shimoda ◽  
Hiroshi Yagata ◽  
...  

2012 ◽  
Vol 23 (5) ◽  
pp. 1144-1150 ◽  
Author(s):  
A. Giordano ◽  
M. Giuliano ◽  
M. De Laurentiis ◽  
G. Arpino ◽  
S. Jackson ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (6) ◽  
pp. e0123683 ◽  
Author(s):  
Sofia Agelaki ◽  
Antonia Kalykaki ◽  
Harris Markomanolaki ◽  
Maria A. Papadaki ◽  
Galatea Kallergi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document